Study to Examine the Effects of MultiStem in Ischemic Stroke

Completed · Phase 2 · Has a placebo group

Conditions studied: Ischemic Stroke

In brief

A study to examine the safety and potential effectiveness of the adult stem cell investigational product, MultiStem, in adults who have suffered an ischemic stroke. The hypothesis is that MultiStem will be safe and provide benefit following an ischemic stroke.

Key facts

Study ID
NCT01436487
Run by
Healios K.K.
People needed
134
Starts
2011-10-01
Expected to finish
2015-12-01
Last updated by the study team
2016-08-02

Who can join

Age: 18 and older, up to 83. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.